Drug Type Small molecule drug |
Synonyms Sarmazenil (INN), R-153505, R-154513 + [3] |
Target |
Mechanism GABAA receptor inverse agonists(Gamma-aminobutyric acid A receptor inverse agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC15H14ClN3O3 |
InChIKeyWSDBAFQWNWJTNG-UHFFFAOYSA-N |
CAS Registry78771-13-8 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D08507 | Sarmazenil | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Cognition Disorders | Phase 1 | - | - | |
Alzheimer Disease | Preclinical | US | - | - |